Ancient schwannoma is a variant of schwannoma and is characterized slowly growing tumor with degenerative change. And it is reported that schwannoma is relatively rare in extensor area. As a rare cause of solitary ancient schwannoma in extensor area of upper arm, we report it.
Arm ; Neurilemmoma

No abstract available.

BACKGROUND: Korea is an endemic area of viral hepatitis B with a rate of 5~10% carrier state. Therefore, hepatitis B vaccination is performed nationwide. But 5~15% of healthy individuals fail to respond adequately to the vaccine and an approved guideline for the nonresponders has not been developed yet. This study is designed to identify risk factors for those who lack anti-HBs after hepatitis B vaccination and to document the results of a double-dose revaccination in such nonresponders to the primary vaccination. METHODS: From Feb. 1996 to Aug, 1997, we assessed 51 healthy subjects(HBs Ag negative, anti-HBs negative, anti-HBc negative and a normal LFT). All subjects were vaccinated with Hepavax- B, 1.0ml, 24 by a rapid schedule(0, 1, and 2 months) and 27 by a standard schedule(0, 1, and 6 months). Anti-HBs titers were evaluated 3 months after the third vaccine and assessed the nonre-sponders (anti-HBs titer<2mIu/ml) and the hyporesponders(2~10mK/ml). All 13 nonresponders were revaccinated with 2ml of Hepavax-B 3 months after the primary vaccination. Anti-HBs titers were evaluated 1 month later. RESULTS: The differences in age(p<0.01) and smoking amount(p<0.05) between the responders and the hypo and the nonresponders were statistically significant. There were more males and higher body mass index in the hypo and the nonresponders but not statistically significant. The seroconversion rate after the double-dose vaccination was 92.3%(12/13) with an average titer of 5K08mlU/ ml(1-132.4mIU/ml). CONCLUSIONS: Increase in age and smoking amount were the risk factors of the nonresponders after the primary vaccination. Most of the hypo and the nonresponders to the primary vaccination responded adequately to the double-dose revaccination.
Body Mass Index ; Carrier State ; Hepatitis B* ; Hepatitis* ; Humans ; Immunization, Secondary* ; Korea ; Male ; Risk Factors* ; Smoke ; Smoking ; Vaccination

Cystic renal cell carcinoma includes any malignant neoplasm of renal tubular epithelium which presents as fluid-filled mass. We reviewed 11 patients of cystic renal cell carcinoma to identify the clinical radiologic and pathologic characteristics of the tumor. The clinical feature of cystic renal cell carcinoma was similar to those which are solid. There are four basic pathologic mechanisms resulting in cystic renal cell carcinoma :intrinsic multiloculated growth (3 patients), intrinsic unilocular growth (1 patient), cystic necrosis (6 patients), and origin from the epithelial lining of a preexisting simple cyst (1 patient). There are three basic radiologic patterns of cystic renal cell carcinoma :unilocular cystic mass (6 patients), multiloculated cystic mass (3 patients), and discrete mural nodule in a cystic mass (2 patients).
Carcinoma, Renal Cell* ; Epithelium ; Humans ; Necrosis

Polycystic ovary syndrome is characterized by symptoms of oligomenorrhea, amenorrhea, infertility, hirsutism and obesity. It is known that the women with such diseases would have higher risks to coronary heart diseases, hypertension, DM and endometrial cancer later on, Known risk factors of endometrial cancer are nullipara, late menopause, obesity, DM, unopposed estrogen, tamoxifen treatment, and atypical endometrial hyperplasia ect. 75% of endometrial cancer occurs in age over 50 and 4% of endometrial cancer occurs in age under 40. Particulary endometrial cancer concurrent polycystic ovary syndrome occurs usually in people under age 40 and is commonly well differentiated cell type and is related to good prognosis. We experienced a case of endometrial cancer with polycystic ovary syndrome, who was early dignosed, presented with infertility and got an operation in our hospital, and report this case with a brief review of literature.
Amenorrhea ; Coronary Disease ; Endometrial Hyperplasia ; Endometrial Neoplasms* ; Estrogens ; Female ; Hirsutism ; Humans ; Hypertension ; Infertility ; Menopause ; Obesity ; Oligomenorrhea ; Polycystic Ovary Syndrome* ; Prognosis ; Risk Factors ; Tamoxifen

PURPOSE: The purpose of this study is to present imaging findings of MMMT developed after irradiation and to compare them with those not associated with irradiation. MATERIALS AND METHODS: Patients with pathologically-proven MMMT were divided into two groups ; group 1, with a history of pelvic irradiation (n=9), and group 2, without such history(n=4). With regard to tumor location, size, extent, degree of myometrial invasion, presence of enhancement, and internal texture of a tumor, we analyzed CT(n=10) and MR imaging (n=8) findings in each group. RESULTS: The tumor was larger in group 1 (average 8.7 cm) than in group 2 (average 5.5 cm). In eight patients in group 1, the endometrial cavity was distended, with remarkable fluid retention, and a mass was found in the fundus or body. The junctional zone was disrupted and hemorrhagic or necrotic foci were found within the mass. In all patients in group 2 and in one in group 1, a tumor had replaced the endometrial cavity, without fluid retention. CONCLUSION: Imaging findings of irradiation-associated MMMT appeared to be different from those not associated with irradiation. Where there are findings of a distended endometrial cavity filled with fluid andmural mass, one should be alert to the possibility of irradiation-associated MMMT.
Humans ; Magnetic Resonance Imaging* ; Uterus*

PURPOSE: The purpose of this study is to present imaging findings of MMMT developed after irradiation and to compare them with those not associated with irradiation. MATERIALS AND METHODS: Patients with pathologically-proven MMMT were divided into two groups ; group 1, with a history of pelvic irradiation (n=9), and group 2, without such history(n=4). With regard to tumor location, size, extent, degree of myometrial invasion, presence of enhancement, and internal texture of a tumor, we analyzed CT(n=10) and MR imaging (n=8) findings in each group. RESULTS: The tumor was larger in group 1 (average 8.7 cm) than in group 2 (average 5.5 cm). In eight patients in group 1, the endometrial cavity was distended, with remarkable fluid retention, and a mass was found in the fundus or body. The junctional zone was disrupted and hemorrhagic or necrotic foci were found within the mass. In all patients in group 2 and in one in group 1, a tumor had replaced the endometrial cavity, without fluid retention. CONCLUSION: Imaging findings of irradiation-associated MMMT appeared to be different from those not associated with irradiation. Where there are findings of a distended endometrial cavity filled with fluid andmural mass, one should be alert to the possibility of irradiation-associated MMMT.
Humans ; Magnetic Resonance Imaging* ; Uterus*

Dieulafoy lesion is an uncommon cause of gastrointestinal bleeding, reported to be only 2% of acute or chronic upper gastrointestinal bleeding episodes. Bleeding occurs from a small mucosal erosion involving an unusually large submucosal artery in an otherwise normal mucosa. It is associated with massive, life threatening hemorrhage and is difficult to diagnosis. In most cases the lesion is encountered in the proximal stomach, antrum, duodenum, colon and rectum. In particular, extragastric Dieulafoy lesion is an extremely rare source of intestinal bleeding. In Korea, no case of bleeding from a Dieulafoy lesion of the small intestine has been previously reported. We experienced one case of bleeding from a jejunal Dieulafoy lesion, which was confirmed by the pathologic examination of the resected specimen, and report here.
Adult ; Arteries/abnormalities* ; Case Report ; Female ; Gastric Mucosa/blood supply* ; Gastrointestinal Hemorrhage/etiology* ; Human ; Intestinal Mucosa/blood supply*

Bladder urothelial carcinoma typically occurs in individuals in their sixties or seventies: it rarely occurs in persons <20 years old. Moreover, in young patients, bladder urothelial carcinoma lesions are reported to be solitary and nonmuscle invasive, with low malignant potential. However, 13% of lesions in this age group are reported to be noninvasive high-grade papillary urothelial carcinoma but these are extremely rare in children <15 years. There is no specific consensus regarding treatment of bladder urothelial carcinoma in children and adolescent. In particular, method has been suggested for follow-up of high-grade bladder urothelial carcinoma. Therefore we report our experience of one case the, discuss surveillance methods, and provide a brief review of the literature.
Adolescent ; Child* ; Consensus ; Follow-Up Studies ; Humans ; Methods ; Pediatrics ; Urinary Bladder*

OBJECTIVE: To determine the accuracy of CT and positron emission tomography (PET) in the diagnosis of recurrent uterine cervical cancer. MATERIALS AND METHODS: Imaging findings of CT and PET in 36 patients (mean age, 53 years) in whom recurrent uterine cervical cancer was suspected were analyzed retrospectively. Between October 1997 and May 1998, they had undergone surgery and/or radiation therapy. Tumor recurrence was confirmed by pathologic examination or follow-up studies. RESULTS: In detecting recurrent uterine cervical cancer, the sensitivity, specificity, and accuracy of CT were 77.8%, 83.3%, and 80.5%, respectively, while for PET, the corresponding figures were 100%, 94.4%, and 97.2%. The Chisquare test revealed no significant difference in specificity (p = .2888), but significant differences in sensitivity (p = .0339) and accuracy (p = .0244). CONCLUSION: PET proved to be a reliable screening method for detecting recurrent uterine cervical cancer, but to determine the anatomical localization of recurrent tumors, and thus decide an adequate treatment plan, CT was eventually needed.
Adult ; Cervix Neoplasms/*radiography/*radionuclide imaging ; Comparative Study ; Contrast Media ; Female ; Fludeoxyglucose F 18/diagnostic use ; Human ; Middle Age ; Neoplasm Recurrence, Local/*radiography/*radionuclide imaging ; Radiopharmaceuticals/diagnostic use ; Sensitivity and Specificity ; *Tomography, Emission-Computed ; *Tomography, X-Ray Computed